ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 22 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2021. The put-call ratio across all filers is 10.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $294,000 | +69.9% | 52,507 | +89.6% | 0.00% | – |
| Q4 2021 | $173,000 | +58.7% | 27,700 | +150.4% | 0.00% | – |
| Q3 2021 | $109,000 | +16.0% | 11,061 | +5.1% | 0.00% | – |
| Q2 2021 | $94,000 | -23.6% | 10,524 | -4.9% | 0.00% | – |
| Q1 2021 | $123,000 | +92.2% | 11,070 | +2.4% | 0.00% | – |
| Q3 2020 | $64,000 | -58.7% | 10,807 | -64.8% | 0.00% | – |
| Q2 2020 | $155,000 | -75.5% | 30,711 | +29.8% | 0.00% | -100.0% |
| Q3 2019 | $632,000 | – | 23,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
| Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
| ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |